-

Eurofins: Purchases of Own Shares From April 7th to April 11th 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins (Paris:ERF):

Name of the Issuer

Identity code of the Issuer

Day of the transaction

Identity code of the financial instrument

Total daily volume (in number of shares)

Daily weighted average purchase price of the shares

Market (MIC Code)

EUROFINS

529900JEHFM47DYY3S57

07/03/2025

FR0014000MR3

117,949

46.5566

XPAR

EUROFINS

529900JEHFM47DYY3S57

07/03/2025

FR0014000MR3

57,724

46.5835

CEUX

EUROFINS

529900JEHFM47DYY3S57

07/03/2025

FR0014000MR3

8,118

46.5843

TQEX

EUROFINS

529900JEHFM47DYY3S57

07/03/2025

FR0014000MR3

8,818

46.5950

AQEU

EUROFINS

529900JEHFM47DYY3S57

08/03/2025

FR0014000MR3

119,027

47.0631

XPAR

EUROFINS

529900JEHFM47DYY3S57

08/03/2025

FR0014000MR3

60,338

47.1450

CEUX

EUROFINS

529900JEHFM47DYY3S57

08/03/2025

FR0014000MR3

8,485

47.1454

TQEX

EUROFINS

529900JEHFM47DYY3S57

08/03/2025

FR0014000MR3

8,737

47.1471

AQEU

EUROFINS

529900JEHFM47DYY3S57

09/03/2025

FR0014000MR3

119,765

46.7822

XPAR

EUROFINS

529900JEHFM47DYY3S57

09/03/2025

FR0014000MR3

61,069

46.7989

CEUX

EUROFINS

529900JEHFM47DYY3S57

09/03/2025

FR0014000MR3

8,637

46.8098

TQEX

EUROFINS

529900JEHFM47DYY3S57

09/03/2025

FR0014000MR3

8,808

46.8186

AQEU

EUROFINS

529900JEHFM47DYY3S57

10/03/2025

FR0014000MR3

106,780

47.3397

XPAR

EUROFINS

529900JEHFM47DYY3S57

10/03/2025

FR0014000MR3

43,093

47.3135

CEUX

EUROFINS

529900JEHFM47DYY3S57

10/03/2025

FR0014000MR3

127

47.8500

AQEU

EUROFINS

529900JEHFM47DYY3S57

11/04/2025

FR0014000MR3

123,180

47.1516

XPAR

EUROFINS

529900JEHFM47DYY3S57

11/04/2025

FR0014000MR3

65,710

47.1966

CEUX

EUROFINS

529900JEHFM47DYY3S57

11/04/2025

FR0014000MR3

5,110

47.1921

TQEX

EUROFINS

529900JEHFM47DYY3S57

11/04/2025

FR0014000MR3

6,000

47.1954

AQEU

 

 

 

TOTAL

937,475

46.9760

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes

Contacts

Eurofins

Eurofins

BOURSE:ERF
Release Versions
English

Contacts

Eurofins

More News From Eurofins

Eurofins Delivers FY 2025 Objectives with a 24% EPS Growth, Accelerating Organic Revenue Growth, Margin Expansion, and Higher Free Cash Flow and Confirms Its 2027 Objectives

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review section of this press release. Financial highlights in FY 2025 Basic EPS8 grew 24% to €2.31 in 2025 vs €1.87 in 2024, driven by a strong operating performance and starting to reap the benefits from Eurofins five-year investment programme in its hub and spok...

Eurofins: Weekly Report on Share Repurchases From 19th January to 23rd January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/01/2026 FR0014000MR3 5 000 71.7101 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 13/01/2026 FR0014000MR3 5 000 70.5398 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 14/01/...

Eurofins CDMO Alphora Announces Development & Implementation of AI-Powered Salt and Co-Crystal Screening Software

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the development and launch of a new AI-powered software for high throughput salt and co-crystal screening – now a core component of all solid-state screening programs. Developed by Eurofins CDMO Alphora, in collaboration with a local university, this cutting-edge machine learning platform provides highly accurate predictions of salt and co-crystal formation for APIs and intermediates. This breakthrough technolog...
Back to Newsroom